A synthetic lethal strategy using PARP and ATM inhibition for overcoming trastuzumab resistance in HER2-positive cancers. Oh KS, Nam AR, Bang JH, Seo HR, et al. Oncogene 2022;41:3939-3952.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Oh KS, Nam AR, Bang JH, Seo HR, et al. A synthetic lethal strategy using PARP and ATM inhibition for overcoming trastuzumab resistance in HER2-positive cancers. Oncogene 2022;41:3939-3952.
PMID: 35798878